Veracyte reported $71K in Ordinary Share Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acceleron Pharma XLRN:US $ 0.06M 0M
Anika Therapeutics ANIK:US $ 0.14M 0M
Biocept BIOC:US $ 0M 0M
Dicerna Pharmaceuticals DRNA:US $ 0.01M 0M
Exact Sciences EXAS:US $ 1.72M 0M
Genmark Diagnostics GNMK:US $ 0.01M 0M
Heron Therapeutics HRTX:US $ 1.02M 0M
Illumina ILMN:US $ 2M 0M
Intrexon XON:US $ 0M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Laboratory Of America LH:US $ 8.8M 0.1M
Ligand Pharmaceuticals LGND:US $ 0.02M 0M
Luminex LMNX:US $ 0.05M 0M
Myriad Genetics MYGN:US $ 0.8M 0M
Rigel Pharmaceuticals RIGL:US $ 0.17M 0M
Sangamo Biosciences SGMO:US $ 1.46M 0M
Siemens SIE:GR € 2550M 0M
Sonic Healthcare SHL:AU $ 4.08B 3.93M
Veracyte VCYT:US $ 0.07M 0M